October 28, 2010
Leslie Carol Botha and Cynthia Ann Janak prepared an extensive power point for the FDA on HPV Vaccines Mechanisms of Action in Women – Endocrine Influence, HPV – Pre Testing and Immune System Involvement. The document was submitted on Monday October 25, 2010.
The FDA declined to make a comment about our research nor did they choose to listen to a verbal presentation of our work – nor did they attempt to answer any questions that we raised on the research presented.
HPV Vaccine Mechanisms of Action in Women is a 63 page PDF document (may take some time to download) filled with research and documentation on issues that were not considered during HPV vaccine clinical trials – nor in any other vaccine or medical trial for that matter.
With all of the studies coming out about the relevance the endocrine system has to women’s health – it is time that the menstrual cycle be given its due as the regulating system in a woman’s body.
The information included in this presentation has implications not only for female adolescent health – but for women ages 26 to 45 and older who may be the next age group the HPV vaccines will be approved for. Our intent was to provide research and data to support our hypothesis that the HPV vaccines may even be more dangerous in this age group in the hopes of preventing FDA approval of Merck’s 4th request to expand Gardasil use to older women.
Download PDF here…
May be a slow download – be patient…
Original power point is also available for presentations and/or webinars.